Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12618001343291Phase 3Recruiting
Phase 3, randomised trial of oxytocin (2 arms), sponsored by Australian Catholic University. Primary endpoint: Emotion Recognition Task performance. Started Jul 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12618001343291.